Camp4 Therapeutics CSO Daniel Tardiff disposes of 1,738 common shares worth $8,272.88
CAMP•Chief scientific officer sells shares
- Camp4 Therapeutics Chief Scientific Officer Daniel Tardiff sold 1,738 common shares on Aug. 19, 2026 at $4.76 per share.
- Direct holdings fell to 0 shares following the transaction.
